GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nutriband Inc (NAS:NTRBW) » Definitions » Loans Receivable

Nutriband (Nutriband) Loans Receivable : $0.00 Mil (As of Apr. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Nutriband Loans Receivable?

Nutriband's Loans Receivable for the quarter that ended in Apr. 2024 was $0.00 Mil.


Nutriband Loans Receivable Historical Data

The historical data trend for Nutriband's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nutriband Loans Receivable Chart

Nutriband Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Loans Receivable
Get a 7-Day Free Trial Premium Member Only - - - - -

Nutriband Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nutriband Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Nutriband Loans Receivable Related Terms

Thank you for viewing the detailed overview of Nutriband's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Nutriband (Nutriband) Business Description

Traded in Other Exchanges
Address
121 South Orange Avenue, Suite 1500, Orlando, FL, USA, 32801
Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.